tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Beximco Pharma Clarifies Media Accusations

Beximco Pharma Clarifies Media Accusations

Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Beximco Pharmaceuticals Ltd has issued a statement to correct recent media reports in Bangladesh accusing the company of money laundering and involvement in fraudulent loans. The company clarified that it holds a minor stake in Jubail Pharma, received through a technology transfer agreement and approved by the Bangladesh Central Bank, but has no operational involvement with Jubail Pharma. Furthermore, Beximco Pharma is not implicated in the loan-related allegations against the Beximco Group and its Non-Executive Vice-Chairman’s legal issues do not affect the company’s daily operations.

For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1